These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 350385

  • 1. 1,2-dihydro-1,2-dihydroxy-5-methylchrysene, a major activated metabolite of the environmental carcinogen 5-methylchrysene.
    Hecht SS, LaVoie E, Mazzarese R, Amin S, Bedenko V, Hoffmann D.
    Cancer Res; 1978 Jul; 38(7):2191-4. PubMed ID: 350385
    [Abstract] [Full Text] [Related]

  • 2. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene.
    Hecht SS, Rivenson A, Hoffmann D.
    Cancer Res; 1980 May; 40(5):1396-9. PubMed ID: 7370979
    [Abstract] [Full Text] [Related]

  • 3. Inhibition by a peri-fluorine atom of 1,2-dihydrodiol formation as a basis for the lower tumorigenicity of 12-fluoro-5-methylchrysene than of 5-methylchrysene.
    Amin S, Camanzo J, Hecht SS.
    Cancer Res; 1984 Sep; 44(9):3772-8. PubMed ID: 6547637
    [Abstract] [Full Text] [Related]

  • 4. Identification of mutagenic metabolites of indeno[1,2,3-cd]pyrene formed in vitro with rat liver enzymes.
    Rice JE, Coleman DT, Hosted TJ, LaVoie EJ, McCaustland DJ, Wiley JC.
    Cancer Res; 1985 Nov; 45(11 Pt 1):5421-5. PubMed ID: 4053016
    [Abstract] [Full Text] [Related]

  • 5. Identification of mutagenic metabolites formed by C-hydroxylation and nitroreduction of 5-nitroacenaphthene in rat liver.
    EL-Bayoumy K, Hecht SS.
    Cancer Res; 1982 Apr; 42(4):1243-8. PubMed ID: 7060001
    [Abstract] [Full Text] [Related]

  • 6. Identification of trans-1,2-dihydro-1,2-dihydroxy-6-nitrochrysene as a major mutagenic metabolite of 6-nitrochrysene.
    El-Bayoumy K, Hecht SS.
    Cancer Res; 1984 Aug; 44(8):3408-13. PubMed ID: 6378368
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and mutagenicity of 5,11-dimethylchrysene and some methyl-oxidized derivatives of 5-methylchrysene.
    Amin S, Hecht SS, LaVoie E, Hoffmann D.
    J Med Chem; 1979 Nov; 22(11):1336-40. PubMed ID: 392098
    [Abstract] [Full Text] [Related]

  • 8. Mutagenicity, metabolism and DNA adduct formation of 6-nitrochrysene in Salmonella typhimurium.
    el-Bayoumy K, Delclos KB, Heflich RH, Walker R, Shiue GH, Hecht SS.
    Mutagenesis; 1989 May; 4(3):235-40. PubMed ID: 2659942
    [Abstract] [Full Text] [Related]

  • 9. Effects of 6-nitro substitution on 5-methylchrysene tumorigenicity, mutagenicity and metabolism.
    el-Bayoumy K, Amin S, Hecht SS.
    Carcinogenesis; 1986 Apr; 7(4):673-6. PubMed ID: 3509952
    [Abstract] [Full Text] [Related]

  • 10. Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin.
    Hecht SS, Radok L, Amin S, Huie K, Melikian AA, Hoffmann D, Pataki J, Harvey RG.
    Cancer Res; 1985 Apr; 45(4):1449-52. PubMed ID: 3838497
    [Abstract] [Full Text] [Related]

  • 11. Influence of bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide:DNA adducts in mouse skin.
    Melikian AA, LaVoie EJ, Hecht SS, Hoffmann D.
    Cancer Res; 1982 Apr; 42(4):1239-42. PubMed ID: 7060000
    [Abstract] [Full Text] [Related]

  • 12. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H, Seidel A, Bochnitschek W, Marquardt H, Marquardt H, Hodgson RM, Grover PL, Oesch F.
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [Abstract] [Full Text] [Related]

  • 13. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.
    Amin S, Huie K, Melikian AA, Leszczynska JM, Hecht SS.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989
    [Abstract] [Full Text] [Related]

  • 14. Reactivity with DNA bases and mutagenicity toward Salmonella typhimurium of methylchrysene diol epoxide enantiomers.
    Melikian AA, Amin S, Huie K, Hecht SS, Harvey RG.
    Cancer Res; 1988 Apr 01; 48(7):1781-7. PubMed ID: 3258179
    [Abstract] [Full Text] [Related]

  • 15. Identification of mutagenic dihydrodiols as metabolites of benzo(j)fluoranthene and benzo(k)fluoranthene.
    LaVoie EJ, Hecht SS, Amin S, Bedenko V, Hoffmann D.
    Cancer Res; 1980 Dec 01; 40(12):4528-32. PubMed ID: 7002294
    [Abstract] [Full Text] [Related]

  • 16. Comparative metabolism and DNA binding of 6-nitro-5-methylchrysene and 5-methylchrysene.
    Shiue GH, el-Bayoumy K, Hecht SS.
    Carcinogenesis; 1987 Sep 01; 8(9):1327-31. PubMed ID: 3621469
    [Abstract] [Full Text] [Related]

  • 17. Effects of fluorine substitution on the tumor initiating activity and metabolism of 5-hydroxymethylchrysene, a tumorigenic metabolite of 5-methylchrysene.
    Amin S, Juchatz A, Furuya K, Hecht SS.
    Carcinogenesis; 1981 Sep 01; 2(10):1027-32. PubMed ID: 7296756
    [Abstract] [Full Text] [Related]

  • 18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA.
    Toxic Rep Ser; 1999 Aug 01; (59):1-66, A1-E7. PubMed ID: 11803702
    [Abstract] [Full Text] [Related]

  • 19. Mutagenicity, tumor-initiating activity, and metabolism of methylphenanthrenes.
    LaVoie EJ, Tulley-Freiler L, Bedenko V, Hoffman D.
    Cancer Res; 1981 Sep 01; 41(9 Pt 1):3441-7. PubMed ID: 7020927
    [Abstract] [Full Text] [Related]

  • 20. Identification of metabolites of 5,11-dimethylchrysene and 5,12-dimethylchrysene and the influence of a peri-methyl group on their formation.
    Amin S, Camanzo J, Hecht SS.
    Carcinogenesis; 1982 Sep 01; 3(10):1159-63. PubMed ID: 7172414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.